Elan Prialt pricing
Executive Summary
Annualized price for Elan's non-opioid pain agent Prialt (ziconotide) for typical patient weighing 70 kg is $18,250, assuming dosing every six weeks. Elan describes Prialt rollout as a "quiet launch" focusing on 50 pain centers. FDA approved the product Dec. 28 and Elan launched the week of Jan. 24 (1"The Pink Sheet" Jan. 3, 2005, p. 4)...
You may also be interested in...
Elan Prialt Clears FDA; Half Of Projected Market Does Not Have Delivery Pump
Elan estimates that more than half of the 120,000 potential users of its non-opioid analgesic Prialt do not already possess an internal drug delivery pump expected to be used in ziconotide administrations
US High Court Punts On ‘Objective Falsity’ FCA Standard
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
Warning Letter Close-Outs – February 2021
No device-related close-out letters were released by the US FDA last month.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: